Put the Efficacy and Safety of Overactive Bladder Meds Into Perspective

You'll see fewer payers requiring a trial of immediate-release oxybutynin for overactive bladder before approving an alternative.

Oxybutynin IR has been the least expensive...but the cost of some of the other antimuscarinics are coming down as more of them go generic.

For mild symptoms of overactive bladder, stick with nondrug measures first...limiting caffeine, bladder training, etc. Explain these strategies can work as well as meds...if patients are diligent.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote